...
首页> 外文期刊>European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology >Treatment strategies according to clinical features in a naturalistic cohort study of bipolar patients: A principal component analysis of lifetime pharmacological and biophysic treatment options
【24h】

Treatment strategies according to clinical features in a naturalistic cohort study of bipolar patients: A principal component analysis of lifetime pharmacological and biophysic treatment options

机译:双相患者自然队列研究中根据临床特征制定的治疗策略:终生药理和生物物理治疗方案的主成分分析

获取原文
获取原文并翻译 | 示例
           

摘要

The treatment of patients with bipolar disorder (BD) is complex and psychiatrists often have to change treatment strategies. However, available data do not provide information about the most frequent patterns of treatment strategies prescribed in clinical practice and clinical/socio-demographic factors of drugs prescription. Objective: The aims of this study were: (1) to identify specific patterns of life-time treatment strategies in a representative sample of bipolar patients; (2) to assess consistency with guidelines recommendations; and (3) to investigate clinical/socio-demographic of patients. Methods: Six-hundred and four BD I and II out-patients were enrolled in a naturalistic cohort study at the Barcelona Bipolar Disorders Program, in a cross-sectional analysis. A principal component analysis was applied to group psychotropic drugs into fewer underlying clusters which represent patterns of treatment strategies more frequently adopted in the life-time naturalistic treatment of BD. Results: Three main factors corresponding to three main prescription patterns were identified, which explained about 60% of cases, namely, Factor 1 (21.1% of common variance), defined the ''antimanic stabilisation package'' including treatments with antimanic mechanism of action in predominantly manic-psychotic BD I patients; Factor 2 (20.4%), ''anti-depressive stabilisation package'' that grouped predominantly depressed patients, and Factor 3 (16.4%) defined the ''anti-bipolar II package'', including antidepressant monotherapy in BD II patients with depressive predominant polarity, melancholic features and higher rates of suicide behaviours. Conclusions: This study identified three patterns of lifetime treatment strategies in three specific and different groups of naturalistically treated bipolar patients.
机译:双相情感障碍(BD)患者的治疗很复杂,精神科医生常常不得不改变治疗策略。但是,现有数据无法提供有关临床实践中规定的最常见治疗策略模式以及药物处方的临床/社会人口统计学因素的信息。目的:本研究的目的是:(1)在双相型患者的代表性样本中确定终生治疗策略的特定模式; (2)评估与准则建议的一致性; (3)研究患者的临床/社会人口统计学。方法:在巴塞罗那双相情感障碍计划中,对六百四名BD I和II型门诊患者进行了一项自然队列研究,进行了横断面分析。应用主成分分析将精神药物分组为更少的潜在类群,这些类群代表了在BD终生自然疗法中更频繁采用的治疗策略模式。结果:确定了与三种主要处方模式相对应的三个主要因素,这些因素解释了约60%的病例,即因素1(共同方差的21.1%)定义了“抗躁狂稳定药包”,包括具有抗躁狂作用机理的治疗在以躁狂症为主的BD I患者中;因子2(20.4%),将主要抑郁患者分组的“抗抑郁稳定药”和因子3(16.4%)定义了“抗双相II药”,包括BD II抑郁患者的抗抑郁单一疗法极性,忧郁特征和较高的自杀行为发生率。结论:本研究确定了三组特定且不同组的自然疗法双相情感障碍患者的终生治疗策略的三种模式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号